Hepatocellular Carcinoma—How to Determine Therapeutic Options
Deciding on specific treatment strategies involves not only tumor stage, performance status, and severity of underlying liver disease, but additional factors such as biomarkers, organ availability, and radiographic tumor response to treatment. In this review, we present hepatocellular carcinoma (HCC...
Main Author: | Neil Mehta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1481 |
Similar Items
-
New Therapeutic Options for Advanced Hepatocellular Carcinoma
by: Yu-Shui Ma PhD, et al.
Published: (2020-08-01) -
Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study
by: Di Ma, et al.
Published: (2020-09-01) -
The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges
by: D'Alessio A, et al.
Published: (2021-03-01) -
Second-line treatment options in hepatocellular carcinoma
by: Donatella Marino, et al.
Published: (2019-04-01) -
Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
by: Liu Q, et al.
Published: (2021-01-01)